|
National Institutes of
Health
Awards Carle Cancer Center
Additional Research Funding
August 29, 2007
Urbana–Carle Cancer Center’s commitment to
research has attracted the attention of the National Cancer
Institute, a division of the National Institutes of Health (NIH).
Recently, the NIH selected the Carle Cancer Center Community
Clinical Oncology program (CCOP) to be one of just a few across the
nation to receive additional funding for research.
As an established CCOP for 24
years, Carle Cancer Center receives annual funding through NIH
grants. Second only to Mayo Clinic in past years, the program
receives the award based on its strong history of high enrollment in
cancer treatment trials.
“This is a great accomplishment
for our center and our patients,” said Kendrith Rowland, MD,
Principal Investigator of Oncology Research at Carle Clinic. “We are
grateful to the patients we serve for their participation in
state-of-the-art clinical trials. The more active we and our
patients are in clinical trials, the more opportunities we have to
bring even more leading-edge care and therapies to our region. In an
age of funding restrictions, this is a major accomplishment.”
Carle Cancer Center currently
offers more than 170 clinical trials for the prevention, control and
treatment of cancer and actively participates in community outreach
and education.
|